MALCOLM JAN
CIK: 0002028640
Associated companies
Transaction History
| UTHR | ▼ Sell | Open Market | 325 | $179K | 7/10/2026 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 650 | $0 | 7/9/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 45 | $24K | 3/17/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 50 | $25K | 3/3/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 50 | $24K | 2/17/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 50 | $24K | 2/3/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 50 | $23K | 1/16/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 50 | $25K | 1/5/2026 | View on chart |
| UTHR | ▼ Sell | Open Market | 50 | $26K | 12/23/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 50 | $24K | 12/11/2025 | View on chart |
| UTHR | ▼ Sell | Open Market | 700 | $280K | 9/9/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 590 | $0 | 7/25/2025 | View on chart |
| UTHR | ▲ Buy | Option Exercise | 630 | $0 | 6/26/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
United Therapeutics Settles Litigation, Market Reassesses Valuation
United Therapeutics has settled a litigation that impacts its pulmonary hypertension business. The settlement resets competition in that market and has led analysts to question whether the stock is undervalued. The move may prompt a reassessment of the company’s value by investors.
United Therapeutics Settles Litigation, Market Reassesses Valuation. United Therapeutics has settled a litigation that impacts its pulmonary hypertension business. The settlement resets competition in that market and has led analysts to question whether the stock is undervalued. The move may prompt a reassessment of the company’s value by investors.